ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 160 filers reported holding ACORDA THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 1.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $43,340,000 | -54.1% | 2,200 | -51.1% | 0.01% | -50.0% |
| Q1 2017 | $94,500,000 | +19.7% | 4,500 | +7.1% | 0.02% | +20.0% |
| Q4 2016 | $78,960,000 | -12.1% | 4,200 | -2.3% | 0.02% | -6.2% |
| Q3 2016 | $89,784,000 | -91.2% | 4,300 | -82.8% | 0.02% | -87.9% |
| Q4 2014 | $1,023,794,000 | +13.8% | 25,050 | -5.6% | 0.13% | +4.8% |
| Q3 2014 | $899,514,000 | +3.6% | 26,550 | +3.1% | 0.13% | +7.7% |
| Q2 2014 | $868,033,000 | -7.1% | 25,750 | +4.5% | 0.12% | -8.6% |
| Q1 2014 | $934,482,000 | +20.5% | 24,650 | -7.2% | 0.13% | +7.6% |
| Q4 2013 | $775,260,000 | -4.4% | 26,550 | +12.3% | 0.12% | -9.8% |
| Q3 2013 | $810,722,000 | -2.7% | 23,650 | -6.3% | 0.13% | -7.7% |
| Q2 2013 | $832,997,000 | – | 25,250 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 428,000 | $8,046,000 | 1.90% |
| SCOPIA CAPITAL MANAGEMENT LP | 4,532,067 | $85,203,000 | 1.61% |
| DLD Asset Management, LP | 247,300 | $4,656,000 | 1.52% |
| Broadfin Capital, LLC | 644,153 | $12,110,000 | 1.34% |
| Perceptive Advisors | 720,000 | $13,536,000 | 0.96% |
| DLD Asset Management, LP | 135,493 | $2,547,000 | 0.83% |
| Malaga Cove Capital, LLC | 51,013 | $971,000 | 0.64% |
| Baker Brothers Advisors | 3,301,791 | $62,074,000 | 0.61% |
| Worth Venture Partners, LLC | 29,300 | $551,000 | 0.59% |
| Spark Investment Management LLC | 327,900 | $6,164,000 | 0.51% |